Your browser doesn't support javascript.
loading
Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival.
Behling, Felix; Rang, Julia; Dangel, Elena; Noell, Susan; Renovanz, Mirjam; Mäurer, Irina; Schittenhelm, Jens; Bender, Benjamin; Paulsen, Frank; Brendel, Bettina; Martus, Peter; Gempt, Jens; Barz, Melanie; Meyer, Bernhard; Tatagiba, Marcos; Skardelly, Marco.
Afiliación
  • Behling F; Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Rang J; Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Dangel E; Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Noell S; Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Renovanz M; Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Mäurer I; Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Schittenhelm J; Department of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Bender B; Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Paulsen F; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Eberhard Karls University of Tübingen, Tuebingen, Germany.
  • Brendel B; Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Martus P; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Eberhard Karls University of Tübingen, Tuebingen, Germany.
  • Gempt J; Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Barz M; Institute of Pathology and Neuropathology, Division of Neuropathology, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tübingen, Germany.
  • Meyer B; Center for Neuro-Oncology, Comprehensive Cancer Center Tuebingen Stuttgart, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Tatagiba M; Department of Neuroradiology, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
  • Skardelly M; University Department of Radiation Oncology, University Hospital Tuebingen, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
Front Oncol ; 12: 755430, 2022.
Article en En | MEDLINE | ID: mdl-35251956
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania